Back to search

Article

Early start of oral clarithromycin is associated with better outcome in COVID-19 of moderate severity: the ACHIEVE open-label trial

2020-12-26

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> To study the efficacy of oral clarithromycin in moderate COVID-19. <h4>Methods</h4> An open-label non-randomized trial in 90 patients with COVID-19 of moderate severity was conducted between May and October 2020. The primary endpoint was defined at the end-of-treatment (EOT) as no need for hospital re-admission and no progression into lower respiratory tract infection (LRTI) f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3488d269-782c-568b-8cc5-cb4c10b1e4fc
DOI
10.1101/2020.12.22.20248753
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Early start of oral clarithromycin is associated with better outcome in COVID-19 of moderate severity: the ACHIEVE open-label trialDOI 10.1101/2020.12.22.20248753
A Randomised Clinical Trial of Azithromycin Versus Standard Care in Ambulatory COVID-19 – The ATOMIC2 TrialSemantic proximity
Efficacy of clarithromycin on COVID-19 pneumonia without oxygen administration; protocol for multicenter, open-label, randomized-controlled, 3-armed parallel group comparison, exploratory trial (CAME COVID study)Semantic proximity
Hydroxychloroquine with or Without Azithromycin for Treatment of Early SARS-CoV-2 Infection Among High-Risk Outpatient Adults: A Randomized Clinical TrialSemantic proximity
Extended effect of short-course azithromycin for the treatment of diarrhoea in children on antimicrobial resistance in nasopharyngeal and intestinal bacteria: Study Protocol for the antimicrobial resistance sub-study of the multicountry AntiBiotics for Children with Diarrhea (ABCD) trialSemantic proximity
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitSemantic proximity
PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardshipSemantic proximity
Therapeutic Combinations in Mild or Moderate COVID-19 to Reduce Nasopharyngeal Carriage of SARS-CoV-2 and Prevent Severe COVID-19 in Côte D’Ivoire: A Pragmatic Phase IIb Randomized Controlled Clinical Trial. The ANRS COV01 INTENSE-COV TrialSemantic proximity
Real-World Effectiveness of Meropenem: Results of an Observational Study in 84 Colombian PatientsSemantic proximity
Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysisSemantic proximity
Adjunctive Use of Oral MAF is Associated with No Disease Progression or Mortality in Hospitalized Patients with COVID-19 Pneumonia: COral-MAF1 TrialSemantic proximity
Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trialSemantic proximity
Treatment with Arbidol and Moxifloxacin in Ordinary and Severe Adult Patients Infected with COVID-19Semantic proximity
Select a neighboring publication to make it the new centre.